Back to Market Feed

ROFLUMILAST 250 MCG TABLET

ROFLUMILAST
$1.9621per EA

Strength

250 ug/1

Manufacturer

Micro Labs Limited

NDC

42571036983

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ROFLUMILAST

Approval Type

Generic (ANDA)

FDA Application

ANDA208180

On Market Since

5/1/2023

Pharmacological Classes

Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors

Price History

1W

0.0%

1M

-8.5%

3M

-14.0%

6M

-16.5%

1Y

-18.1%

3Y

N/A

5Y

N/A

All

-75.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ROFLUMILAST 500 MCG TABLET
Generic
00904739946•Major Pharmaceuticals
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
00904739989•Major Pharmaceuticals
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
00904748303•Major Pharmaceuticals
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
00904748389•Major Pharmaceuticals
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
31722062330•Camber Pharmaceuticals Inc.
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
31722062390•Camber Pharmaceuticals Inc.
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
42571025930•Micro Labs Limited
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
43547000503•Solco Healthcare US LLC
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
43547000509•Solco Healthcare US LLC
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
60687078621•American Health Packaging
$0.3187
per EA